Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2005-11-18
pubmed:abstractText
Although catecholamine is a well-known classical hormone, its precise pathophysiological role remains obscure. Recently, growing evidence suggests that this hormone plays a causative role in several common diseases such as hypertension, diabetes, and dyslipidemia (metabolic syndrome). Thus, the discussion that follows will mainly focus on our data, including: 1) leptin as well Ang II subtype-2 receptor (AT2), assumed to be a key molecule for metabolic syndrome, much involved in regulating catecholamine synthesis and secretion. 2) Recent progress of pheochromocytoma (SDHX and Peptidergic Regulation). 3) Chromogranin A, as a possible marker for chronic sympatho-adrenal activities.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines, http://linkedlifedata.com/resource/pubmed/chemical/Chromogranin A, http://linkedlifedata.com/resource/pubmed/chemical/Chromogranins, http://linkedlifedata.com/resource/pubmed/chemical/Iron-Sulfur Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Leptin, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2, http://linkedlifedata.com/resource/pubmed/chemical/SDHB protein, human, http://linkedlifedata.com/resource/pubmed/chemical/SDHD protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Succinate Dehydrogenase
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0047-1860
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
927-34
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16296341-Adrenal Gland Neoplasms, pubmed-meshheading:16296341-Autonomic Nervous System Diseases, pubmed-meshheading:16296341-Biological Markers, pubmed-meshheading:16296341-Catecholamines, pubmed-meshheading:16296341-Chromogranin A, pubmed-meshheading:16296341-Chromogranins, pubmed-meshheading:16296341-Chronic Disease, pubmed-meshheading:16296341-Humans, pubmed-meshheading:16296341-Iron-Sulfur Proteins, pubmed-meshheading:16296341-Leptin, pubmed-meshheading:16296341-Membrane Proteins, pubmed-meshheading:16296341-Metabolic Syndrome X, pubmed-meshheading:16296341-Mutation, pubmed-meshheading:16296341-Pheochromocytoma, pubmed-meshheading:16296341-Protein Subunits, pubmed-meshheading:16296341-Receptor, Angiotensin, Type 2, pubmed-meshheading:16296341-Succinate Dehydrogenase
pubmed:year
2005
pubmed:articleTitle
[Recent progress of catecholamines--mainly focusing on metabolic syndrome].
pubmed:affiliation
Department of Clinical Pathology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575.
pubmed:publicationType
Journal Article, English Abstract, Review